glp 1 meds for addiction GLP-1 medications get at the heart of addiction: study – WashU Medicine GLP-1 Agonists Show Promise in
Description
A weight-loss pill that works
Looking forward to connecting with more people working in bioprocess and CDMO spaces
Discover the timeline of this dual-agonist medication, from its 2022 FDA approval to its role in modern weight loss programs.
Are you on a GLP-1? Studies show up to 40% of weight lost on GLP-1 medications may come from lean body mass, including muscle
The novel incretin agonist, named I-M-150847, promotes robust glucose-stimulated insulin exocytosis in cultured pancreatic beta cells
